Instinct Science Acquires VetMedux (Clinician's Brief & Plumb's)

Mainsail Partners Makes Growth Equity Investment in Instinct Science

November 28, 2022

Cloud & SaaS

Mainsail Partners, a growth equity firm, made a growth equity investment in Instinct Science, a veterinary practice management SaaS platform. The capital will be used to accelerate product development and expand services and support for veterinary hospitals; financial terms were not disclosed and the investment closed in the first half of 2022.

Instinct Science Acquires ScribbleVet

January 23, 2026

Veterinary

Instinct Science, a veterinary software and clinical tools company, has acquired ScribbleVet, an AI scribing platform for veterinarians. The deal brings ScribbleVet's AI documentation capabilities into Instinct's EMR and clinical workflow to create an intelligence-native veterinary practice management platform; ScribbleVet's team will join Instinct and its founder Rohan Relan will take a product leadership role.

Dechra Pharmaceuticals to Acquire Invetx

July 18, 2024

Biotechnology

Dechra Pharmaceuticals Limited has agreed to acquire Boston-based Invetx Inc., a developer of species-specific monoclonal antibody therapeutics for companion animals, for up to $520 million on a cash-free, debt-free basis, subject to customary approvals. The deal gives Dechra access to Invetx's pipeline and half-life extension platform to expand its specialty veterinary biologics capabilities.

IMV Technologies Acquires UD-Vet B.V.

September 26, 2024

Veterinary

French animal health equipment maker IMV Technologies has acquired UD-Vet B.V., a Benelux-based provider of veterinary practice equipment and imaging solutions. The deal brings UD-Vet's team and product/service offering into IMV's Companion Animal business to consolidate and expand IMV's presence in the Benelux region.

IMV Technologies Group Acquires Medivet Scandinavian AB

June 6, 2024

Medical Devices

IMV Technologies Group has acquired Medivet Scandinavian AB, a Sweden-based provider of veterinary DR X‑ray systems and other imaging modalities headquartered in Ängelholm. The acquisition expands IMV's companion animal imaging business and adds Medivet’s equine MERS X‑ray capability and Scandinavian market presence.

Velocity Clinical Research Acquires MedPharmics

September 7, 2022

Healthcare Services

Velocity Clinical Research, a portfolio company of GHO Capital, has acquired MedPharmics, a U.S.-based multi-site clinical research organization. The add-on expands Velocity's network by eight sites (bringing it to 40 locations), adds just over 100 employees, and improves access to diverse patient populations including African American and Native American communities.